Biomarkers for immune thrombocytopenia

详细信息    查看全文

• 作者：Lingjia Yu ; Chunmei Zhang ; Liping Zhang ; Yongyu Shi ; Xuebin Ji
• 关键词：Immune thrombocytopenia ; Biomarker ; T cell ; B cell ; Pathogenesis
• 刊名：Biomarker Research
• 出版年：2015
• 出版时间：December 2015
• 年：2015
• 卷：3
• 期：1
• 全文大小：350 KB
• 刊物主题：Biomedicine general;
• 出版者：BioMed Central
• ISSN：2050-7771

文摘

Immune thrombocytopenia is an autoimmune disease with abnormal biomarkers. Immune thrombocytopenia pathogenesis is a complicated process in which the patient’s immune system is activated by platelet autoantigens resulting in immune mediated platelet destruction or suppression of platelet production. The autoantibodies produced by autoreactive B cells against self antigens are considered to play a crucial role. In addition, biomarkers such as transforming growth factor-beta1,Toll-like receptors,T helper 1 andT helper 2 cytokine bias, Notch signaling and abnormal biomarker in megakaryocyte maturation are involved in the pathogenesis of this disease. With the genomewide association study on immune thrombocytopenia, more biomarkers will be founded in the future. They may provides a theoretical basis for the mechanism and treatment of immune thrombocytopenia.